Sofinnova Investments as of June 30, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 11.6 | $127M | 1.1M | 115.15 | |
Amarin Corporation (AMRN) | 9.3 | $101M | 5.2M | 19.39 | |
Natera (NTRA) | 7.9 | $86M | 3.1M | 27.58 | |
Principia Biopharma | 6.2 | $68M | 2.0M | 33.19 | |
Obseva Sa | 4.9 | $54M | 4.7M | 11.31 | |
Spark Therapeutics | 4.5 | $49M | 481k | 102.38 | |
Y Mabs Therapeutics (YMAB) | 4.4 | $48M | 2.1M | 22.87 | |
Coherus Biosciences (CHRS) | 4.2 | $46M | 2.1M | 22.10 | |
Nextcure (NXTC) | 3.5 | $38M | 2.5M | 14.98 | |
Audentes Therapeutics | 3.2 | $35M | 934k | 37.86 | |
Karuna Therapeutics Ord (KRTX) | 3.2 | $35M | 1.7M | 20.02 | |
Merus N V (MRUS) | 2.6 | $29M | 2.0M | 14.65 | |
Nucana Biomed ordinary shares | 2.3 | $25M | 2.4M | 10.38 | |
Nucana Plc american depositary shares (NCNA) | 2.2 | $24M | 2.3M | 10.38 | |
Ptc Therapeutics I (PTCT) | 1.5 | $17M | 369k | 45.00 | |
Novo Nordisk A/S (NVO) | 1.5 | $17M | 324k | 51.04 | |
Allergan | 1.3 | $14M | 84k | 167.42 | |
Neurocrine Biosciences (NBIX) | 1.2 | $13M | 156k | 84.42 | |
Kiniksa Pharmaceuticals (KNSA) | 1.1 | $13M | 923k | 13.54 | |
Chiasma | 1.1 | $12M | 1.6M | 7.47 | |
Halozyme Therapeutics (HALO) | 1.1 | $12M | 690k | 17.18 | |
Iterum Therapeutics | 1.1 | $12M | 1.7M | 6.88 | |
Heron Therapeutics (HRTX) | 1.1 | $12M | 617k | 18.59 | |
Tg Therapeutics (TGTX) | 1.0 | $11M | 1.3M | 8.65 | |
Reata Pharmaceuticals Inc Cl A | 1.0 | $11M | 116k | 94.36 | |
Acceleron Pharma | 0.9 | $9.9M | 241k | 41.08 | |
Macrogenics (MGNX) | 0.9 | $9.3M | 550k | 16.97 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $9.2M | 50k | 183.40 | |
Amgen Inc option | 0.8 | $9.2M | 50k | 184.28 | |
Morphosys (MPSYF) | 0.8 | $9.2M | 96k | 96.01 | |
Allergan Plc call | 0.8 | $8.4M | 50k | 167.44 | |
Bristol Myers Squibb (BMY) | 0.7 | $7.9M | 174k | 45.34 | |
Entasis Therapeutics Holdings Ord | 0.7 | $7.6M | 1.2M | 6.45 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $7.3M | 85k | 85.65 | |
Amicus Therapeutics (FOLD) | 0.7 | $7.3M | 583k | 12.48 | |
Dermira | 0.6 | $6.3M | 660k | 9.56 | |
Incyte Corporation (INCY) | 0.5 | $5.9M | 70k | 84.97 | |
Synlogic | 0.5 | $5.2M | 575k | 9.10 | |
Orchard Therapeutics Plc ads | 0.5 | $5.1M | 366k | 13.99 | |
Bristol-myers Squibb | 0.4 | $4.5M | 100k | 45.35 | |
Kadmon Hldgs | 0.4 | $4.5M | 2.2M | 2.06 | |
ACADIA Pharmaceuticals (ACAD) | 0.4 | $4.2M | 156k | 26.73 | |
Akebia Therapeutics (AKBA) | 0.4 | $4.1M | 848k | 4.84 | |
Aclaris Therapeutics (ACRS) | 0.4 | $4.2M | 1.9M | 2.19 | |
Zymeworks | 0.4 | $4.1M | 188k | 21.99 | |
Uniqure Nv (QURE) | 0.4 | $3.9M | 50k | 78.17 | |
Otonomy | 0.3 | $3.7M | 1.3M | 2.75 | |
ArQule | 0.3 | $3.1M | 282k | 11.01 | |
Foamix Pharmaceuticals | 0.2 | $2.7M | 1.1M | 2.38 | |
Xbiotech (XBIT) | 0.2 | $2.5M | 332k | 7.58 | |
Zogenix Inc call | 0.2 | $2.4M | 50k | 47.79 | |
Intra Cellular Therapies | 0.2 | $2.3M | 175k | 12.98 | |
Syndax Pharmaceuticals (SNDX) | 0.2 | $2.3M | 243k | 9.32 | |
Deciphera Pharmaceuticals In put | 0.2 | $2.3M | 100k | 22.56 | |
Adverum Biotechnologies (ADVM) | 0.2 | $2.2M | 187k | 11.89 | |
Alnylam Pharmaceuticals (ALNY) | 0.2 | $2.0M | 28k | 72.54 | |
Abbvie (ABBV) | 0.2 | $2.1M | 29k | 72.74 | |
Calithera Biosciences | 0.2 | $2.1M | 530k | 3.90 | |
Osmotica Pharmaceuticals (RVLPQ) | 0.2 | $2.0M | 525k | 3.80 | |
Clovis Oncology | 0.2 | $1.9M | 125k | 14.88 | |
Kala Pharmaceuticals | 0.2 | $1.9M | 297k | 6.38 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.6M | 426k | 3.79 | |
Intra Cellular Therapies (ITCI) | 0.1 | $1.6M | 126k | 12.98 | |
Acorda Therapeutics | 0.1 | $1.5M | 194k | 7.66 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $1.3M | 50k | 25.33 | |
Forty Seven | 0.1 | $1.3M | 119k | 10.59 | |
Applied Therapeutics (APLT) | 0.1 | $1.2M | 142k | 8.24 | |
Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $1.1M | 66k | 16.09 | |
Pds Biotechnology Ord (PDSB) | 0.1 | $854k | 143k | 5.99 |